Today, the Alliance to Modernize Prescribing Information — AMPI — a coalition of cross-industry healthcare stakeholders created to reduce prescribing label waste and improve patient safety, announced the addition of two new members — Bristol Myers Squibb and Fresenius Kabi.
Founded by members AbbVie, AmerisourceBergen, Johnson & Johnson, Merck, Pfizer, Teva, and Viatris — AMPI is working more specifically to advance policy reforms to modernize the antiquated paper prescribing labeling requirements for prescription drugs. While physicians and pharmacists almost exclusively rely on the digital versions of these labels, manufacturers are still required to produce printed paper labels that are redundant and discarded. For those without digital access, paper versions would be available to them upon request.
